Jiangsu Hengrui Pharmaceuticals Co.Ltd (1276.HK) announced a profit for its full year that Increased, from the same period last year
The company's bottom line totaled RMB7.711 billion, or RMB1.18 per share. This compares with RMB6.336 billion, or RMB1.00 per share, last year.
The company's revenue for the period rose 13.0% to RMB31.629 billion from RMB27.984 billion last year.
Jiangsu Hengrui Pharmaceuticals Co.Ltd earnings at a glance (GAAP) :
-Earnings: RMB7.711 Bln. vs. RMB6.336 Bln. last year.-EPS: RMB1.18 vs. RMB1.00 last year.-Revenue: RMB31.629 Bln vs. RMB27.984 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.